Novavax, Inc. (NVAX)
8.42
-0.55
(-6.13%)
USD |
NASDAQ |
Feb 12, 16:00
8.50
+0.08
(+0.95%)
Pre-Market: 09:28
Novavax Cash from Investing (Quarterly) : -136.53M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -- |
| Pfizer Inc. | -- |
| Moderna, Inc. | 700.00M |
| Plus Therapeutics, Inc. | 1.297M |
| INVO Fertility, Inc. | -0.0081M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 107.80M |
| Cash from Financing (Quarterly) | 42.44M |
| Free Cash Flow | -384.71M |
| Free Cash Flow Per Share (Quarterly) | 0.6516 |
| Free Cash Flow to Equity (Quarterly) | 83.14M |
| Free Cash Flow to Firm (Quarterly) | 111.25M |
| Free Cash Flow Yield | -26.98% |